glp-1 brain inflammation and the Degenerating Brain: Exploring Mechanistic Insights and Therapeutic Potential Could diabetes and weight loss

The guide on switching from tirzepatide to semaglutide covers the logistics and expectations

Recent advances in the design of choline kinase alpha inhibitors and the molecular basis of their inhibition

Educational sponsorship has been provided by BD, Boehringer Ingelheim, Lilly, MSD, Mylan and Novo Nordisk

On the opportunity front, emerging markets with large diabetic populations, increasing acceptance of biosimilars in developed countries, advancements in biomanufacturing technologies, and the potential for new indications beyond diabetes and obesity (such as cardiovascular and neurodegenerative diseases) present significant growth potential

:) Fat Rebecca - 09 July 2019 L carnitine is the bees knees